YahooOctober 22, 2026 at 4:52 PM NY4 Days Ago
Biogen +5% on BofA Price Target Hike Ahead of “Relatively Quiet” Q3
Key TakeawaysBiogen shares rose 5% today after BofA raised its price target to $244 from $219 and kept a Neutral rating. BofA’s new target is close to the $247 consensus target, which has climbed 43% over the past year as analysts try to keep up with the stock.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Yahoo
